Business Context and Reporting Period
Company: Omeros Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: August 7, 2012
Reporting Period: The filing announces financial results for the three and six months ended June 30, 2012.
Key Financial Metrics
The provided text is a cover document referencing a press release (Exhibit 99.1) containing the actual financial data. The filing text itself does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not contain specific data regarding material changes versus prior comparable periods. It only confirms the issuance of a press release detailing results for the periods ended June 30, 2012.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are contained within the referenced press release (Exhibit 99.1), which is not included in the input text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 7, 2012) for specific revenue, net loss, and cash position figures.
- Verify the status of clinical trials and product development pipelines mentioned in the press release.
- Confirm liquidity runway and capital requirements as detailed in the full financial results.
- Check for any updates on regulatory approvals or partnerships announced in the referenced exhibit.